Physician profile
Eric M Smith
NPI 1578561700
$6,041.49
in general payments reported to CMS, 2019-2025
45 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $826 · 2020: $1,029 · 2021: $1,215 · 2022: $1,142 · 2023: $1,099 · 2024: $550 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,830.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $769.73 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $700.82 | 2019-2024 | Xtandi |
| Antares Pharma, INC. | $506.99 | 2019-2024 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $416.57 | 2019-2024 | Aveed, Xiaflex |
| Pfizer INC. | $388.33 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $375.00 | 2019-2024 | |
| Abbvie INC. | $289.45 | 2019-2023 | Botox |
| Sumitomo Pharma America, INC. | $184.57 | 2023-2024 | Gemtesa, Orgovyx |
| Accord Healthcare, INC. | $170.22 | 2022-2024 | |
| Coloplast Corp | $165.46 | 2019-2025 | |
| Myovant Sciences INC. | $151.15 | 2021-2022 | |
| Medtronic, INC. | $150.42 | 2021-2024 | Interstim |
| Astrazeneca Pharmaceuticals Lp | $140.18 | 2020-2023 | Lynparza |
| Boston Scientific Corporation | $132.99 | 2019-2023 | Rezum Generator |
| Tolmar Pharmaceuticals, INC. | $125.44 | 2019-2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.